Guidant FUTURE Results Show No In-Stent Restenosis At Six Months

Late lumen loss rates observed in Guidant's FUTURE I/II everolimus-eluting stent trials are consistent with J&J/Cordis' SIRIUS data, according to investigator Eberhard Grube, MD, Heart Center Sieburg, Germany